Efgartigimod as a fast-acting add-on therapy in manifest and impending myasthenic crisis: A single-center case series. Hong Y, Gao L, Huang SQ, Liu S, et al. J Neuroimmunol 2024;395:578431.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hong Y, Gao L, Huang SQ, Liu S, et al. Efgartigimod as a fast-acting add-on therapy in manifest and impending myasthenic crisis: A single-center case series. J Neuroimmunol 2024;395:578431.
PMID: 39142025